McLoughlin Karen has filed 7 insider transactions across 2 companies since April 2023.
Most recent transaction: a grant/award of 2946 shares of BEST BUY CO INC ($BBY) on June 13, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2025 | BEST BUY CO INC | $BBY | McLoughlin Karen | Director | A | Common Stock | 2946 | $0.00 | 36,984.0000 | 216,600,000 | 8.66% | 0.00% |
| May 28, 2025 | agilon health, inc. | $AGL | McLoughlin Karen | Director | A | Common Stock | 78724 | $0.00 | 151,890.0000 | 412,303,066 | 107.60% | 0.02% |
| Dec. 13, 2024 | agilon health, inc. | $AGL | McLoughlin Karen | Director | P | Common Stock | 25000 | $2.20 | 73,166.0000 | 0 | 51.90% | 0.00% |
| June 12, 2024 | BEST BUY CO INC | $BBY | McLoughlin Karen | Director | A | Common Stock | 2258 | $0.00 | 33,083.0000 | 218,500,000 | 7.33% | 0.00% |
| May 29, 2024 | agilon health, inc. | $AGL | McLoughlin Karen | Director | A | Common Stock | 32119 | $0.00 | 48,166.0000 | 0 | 200.16% | 0.00% |
| June 14, 2023 | BEST BUY CO INC | $BBY | McLoughlin Karen | Director | A | Common Stock | 2545 | $0.00 | 30,034.0000 | 225,700,000 | 9.26% | 0.00% |
| April 14, 2023 | agilon health, inc. | $AGL | McLoughlin Karen | Director | A | Common Stock | 5622 | $0.00 | 16,047.0000 | 0 | 53.93% | 0.00% |